AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

AstraZeneca ... AstraZeneca plc (/ ˌæstrəˈzɛnəkə /) (AZ) is a British-Swedish [3][4][5] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge …

Oncology: Start with One At AstraZeneca, we are leading a revolution in oncology to redefine cancer care for the millions of Americans living with cancer. It’s a lofty ambition.

Nov 21, 2025 · AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion...

3 days ago · The latest international AstraZeneca PLC news and views from Reuters - one of the world's largest news agencies

AstraZeneca is a British-Swedish biopharmaceutical company with medicine sales in more than 130 countries, making it one of the largest drug companies in the world.

Jul 22, 2025 · AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by …

1 day ago · Seven years after the FDA's accelerated approval of bleeding reversal agent Andexxa, which was then under the ownership of Portola Pharmaceuticals, the drug's round …

Dec 10, 2025 · AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about AZN stock here.

Dec 12, 2023 · AstraZeneca has agreed to buy its first vaccine company in a deal worth up to $1.1bn, as the pharma group expands the infectious disease division it set up during the …